NUTLEY, N.J., Oct. 31 /PRNewswire/ -- Maximizing on the momentum gained during Breast Cancer Awareness Month, healthcare providers and advocacy organizations now have a helpful resource to offer cancer patients -- OralChemoAdvisor.com -- an educational, state-of-the-art Web site about oral chemotherapy. This straightforward, credible site is designed to help cancer patients and their family members make more informed healthcare decisions concerning oral chemotherapy treatment.
“There is a general lack of awareness about oral chemotherapy as a treatment option despite the overwhelming amount of resources dedicated to cancer patients,” said Lars E. Birgerson, Vice President of Medical Affairs at Roche, which created and launched the site. “OralChemoAdvisor.com is specifically designed to help patients locate relevant information to help them better understand and assist in managing their treatment.”
OralChemoAdvisor.com offers direct and easy access to a variety of educational tools designed to help patients who want to learn more about oral chemotherapy and its efficacy, risks and benefits. The site contains a unique video component that gives patients the option of interacting with oncology medical professionals and helps ensure that new information is retained. The expert videos include guides on oral chemotherapy treatment and patient-doctor communication, both of which also are available in written form. And, OralChemoAdvisor.com offers a list of oral chemotherapy treatments indicated for specific types of cancer, answers to frequently asked questions, and expert insights on cancer management and treatment.
“It is so important for breast cancer patients to have access to the most up-to-date information and resources. Web sites such as oralchemoadvisor.com are an important option for patients to help them make informed decisions about their individual course of treatment,” stated Margaret C. Kirk, Chief Executive Officer, Y-ME National Breast Cancer Organization.
According to a recent survey conducted by Manhattan Research, CyberCitizen Health more than 14 million patients and caregivers went online in 2006 to gather information specific to oncology.
About Roche
Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world’s leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people’s health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News and one of the Top 20 Employers (Science magazine). In 2006, Roche was ranked the No.1 Company to Sell For (Selling Power), and one of AARP’s Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine’s Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or www.roche.us
CONTACT: Ginny Valenze of Roche, +1-973-562-2783, or
virginia.valenze@roche.com; or Daphne Hoytt of Manning Selvage & Lee,
+1-212-468-3558, or Cell, +1-917-406-2779, or daphne.hoytt@mslpr.com
Web site: http://www.rocheusa.com/
http://www.roche.us/
http://www.OralChemoAdvisor.com/
